Indian Observers

Top Menu

  • Facebook
  • Twitter
  • Youtube
  • Medium

Main Menu

  • Home
  • Top News
  • National
  • Politics
  • Business
  • Technology
  • Sports
  • Entertainment
  • Facebook
  • Twitter
  • Youtube
  • Medium

logo

Indian Observers

  • Home
  • Top News
  • National
  • Politics
  • Business
  • Technology
  • Sports
  • Entertainment
  • Tata Jumps The Bandwagon To Develop Vaccine With Moderna In India

  • Startup ‘Neeva’ gears up to take on Google search engine

  • India’s COVID-19 vaccination drive is now the world’s fastest

  • Mamata Might Have Competition In Muslim Cleric Leader

  • India administers one million vaccine doses against Covid-19

BusinessTop News
Home›Business›Sun Pharma to provide affordable Medicine for Covid-19 patients

Sun Pharma to provide affordable Medicine for Covid-19 patients

By india_observers
August 7, 2020
77
0
Covid19 drug

India is seeing an increasing use of the medicines like Favipiravir, along with another antiviral, remdesivir by hospitals in the tackling of the Covid-19 virus. Looking at the increasing number of cases per day, Sun Pharmaceutical Industries is now coming out with its own version of Favipiravir called FluGuard that is to cost Rs. 35 per 200mg tablet.

This has become the cheapest version of a medicine available to tackle the Covid-19 virus in India.

India has become the world’s third worst hit country with the Covid-19 virus. Originally developed by Japan’s Fujifilm Holdings Corp as Avigan, Favipiravir somehow, does not have good prospects showing in Japan itself. This is because despite hype around its usage as a potential Covid-19 treatment by Japan’s prime minister, Avigan faced uncertain prospects in the country, dampened by disappointing clinical studies.

But somehow the same drug has received emergency approval in India in June that has been trying to tackle the cases through various means. Another Indian drugmaker, Jubilant Life Sciences Ltd has also announced the launch of its version of remdesivir. Priced at Rs. 4700 per 100 mg, it is in vial form and therefore will prove to be more effective but does not work well for the general public on its pricing. Also, this is to be used in emergency cases only as stated by the company’s official statements made earlier and should not be administered as general treatment.

Jubilant is among the companies producing the drug under licence from U.S. based Gilead Sciences Inc. In July, the Drug Controller General Of India (DCGI) had given approval for a generic version of the Remdesivir drug to be administered intravenously.  It was launched under brand name Desrem and was to be used in restricted emergency cases for Covid-19 patients. This drug came into high demand after the intravenously-administered medicine has shown excellent results in shortening hospital recovery times in a clinical trial.

It has also received conditional approval from the European Commission for use in severe COVID-19 patients. According to Health Ministry, Remdesivir being an extremely expensive drug, is recommended to be used only on extreme cases that are on oxygen support. Under clinical trials, the drug is not recommended for pregnant or lactating mothers and children below the age of 12 years or for patients with severe renal impairment and a high level of liver enzymes.

TagsCOVID-19FavipiravirIndiaRemdesivirSun Pharmaceuticals
Previous Article

Pakistan & China’s attempts to raise Kashmir ...

Next Article

EC hires BJP-linked social media firms

Related articles More from author

  • ODI series
    Sports

    India lacks in seam attack as Australia assures ODI series winning two successive matches

    November 30, 2020
    By Uttara J Malhotra
  • Ministry of Petroleum and Natural Gas, demand of even refined oil
    NationalTop News

    Indian Oil Consumption Slow Even After Lockdown Opens Up

    August 13, 2020
    By Nilotamma Joshi
  • Covid19

    How this small district has kept itself safe of Covid-19?

    April 27, 2020
    By Nilotamma Joshi
  • Veerappa Moily
    PoliticsTop News

    Veerappa Moily slams centre for sadistically hiking fuel prices amidst COVID-19

    June 23, 2020
    By Rashmi Sacher
  • HCQ-Tablet
    CoronavirusTop News

    ICMR recommends use of HCQ as prophylactic against COVID-19

    May 23, 2020
    By Staff Writer
  • Indian Vaccine Export
    Top News

    Indian Government Restricts Poonawalla To Export Indian Vaccine

    January 4, 2021
    By Uttara J Malhotra

You might be interested

  • Rajiv_Gandhi_Rajiv_Bajaj
    BusinessNationalPoliticsTop News

    Bajaj MD nails the India pandemic response as ‘Wild West’

  • Sushant Singh Rajput sister
    Entertainment

    Cops hint at Sushant Singh Rajput’s sister’s hand in his murder

  • Nation_India
    NationalTop News

    One Nation-One Ration-One India

Technology

Startup ‘Neeva’ gears up to take on Google search engine

For over 22 years, Google has been the most predominant web search engine in the world. Vivek Raghunathan and Sridhar Ramaswamy, former Google executives and IIT alumni, a start-up company ...
  • Indian startups

    Indian startups to receive Antler investments worth $100 million

    By Dr Neha Mathur
    January 21, 2021
logo

Follow Us

Sitemap
Contact Us

  • Latest Posts

  • Tata Jumps The Bandwagon

    Tata Jumps The Bandwagon To Develop Vaccine With Moderna In India

    By Uttara J Malhotra
    January 25, 2021
  • Startup ‘Neeva’

    Startup ‘Neeva’ gears up to take on Google search engine

    By G. Morrison
    January 25, 2021
  • India's COVID-19 vaccination drive

    India’s COVID-19 vaccination drive is now the world’s fastest

    By Monica Aggarwal
    January 25, 2021

Trending this Week

  • January 25, 2021

    India’s COVID-19 vaccination drive is now the world’s fastest

  • January 22, 2021

    Serum Institute of India building catches fire, five dead, vaccine facility remains unaffected

  • January 21, 2021

    Palanisawmi says met Modi and Shah, to discuss TN growth plan, not politics

© Copyright 2020 - India Observers.